Because BAZ1A is associated with CCAR2 in SFN-treated colon cancer cells [27], and CCAR2 is part of the DBIRD complex that regulates alternative mRNA splicing [45], the corresponding molecular targets were examined mechanistically. The gene discussed is BAZ1A; the disease is malignant colon neoplasm.